Locations:
Search IconSearch

Research

clinical-trials-690-x-380
June 8, 2015/Cancer/Research

June Featured Cancer Clinical Trials

Learn about featured clinical trials currently enrolling or search our trials database

15-CCC-143 SOTC Hero Image 690x380pxl
March 9, 2015/Cancer/Research

New VEGF-A Variant May Be Cancer Inhibitor (Video)

Cell study upends thinking about VEGF-A

ASH2014_690x380
December 9, 2014/Cancer/Research

Hope for Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Combination therapy shows improved response in some

advani_690x480
December 8, 2014/Cancer/Research

Novel Antibody-Drug Conjugate Targets CD33-Positive AML

SGN-CD33A demonstrates encouraging antileukemic activity

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Mouse-tumors-control-(left)-and-VEGF-Ax-690-x-380
October 15, 2014/Cancer/Research

Can a VEGF-A Variant Help Halt the Spread of Cancer?

A new discovery may help slow the growth of tumors — and change the research and treatment of cancer.

clinical-trials-690-x-380
October 13, 2014/Cancer/Research

October Featured Clinical Trials

Learn about featured clinical trials currently enrolling or search our trials database

HNSCC-690 x 380
May 16, 2014/Cancer/Research

HNSCC: Outpatient ChemoRT Regimen Offers Outcomes Equal to Inpatient at Lower Cost

An overarching goal of healthcare delivery is to improve the value of care defined as patient outcomes per dollar spent. With that in mind, a recent Cleveland Clinic study of two chemoradiation (ChemoRT) regimens for stage III-IV squamous cell carcinoma of head and neck (HNSCC) compared the outcomes and costs of the protocols.

BackPage 31 of 31Next

Advertisement

Ad